A total of five drugs, Acetaminophen, Estradiol, Cyclosporine, Calcitriol, and Seocalcitol (Table 1), demonstrated the capability to potentially reduce the expression levels of OAS1, OAS2, OAS3, and OASL, suggesting their prospective use in breast cancer treatment. Here, OAS3 is linked to breast carcinoma.